Jane Street’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Jane Street’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,100	Closed	-$333K	–	5752
2018 Q1	$333K	Buy	+5,100	New	+$361K	﹤0.01%	3907
2017 Q4	–	Sell	-8,578	Closed	-$786K	–	5296
2017 Q3	$786K	Buy	+8,578	New	+$658K	﹤0.01%	2555
2017 Q2	–	Sell	-1,600	Closed	-$347K	–	4986
2017 Q1	$347K	Buy	+1,600	New	+$229K	﹤0.01%	3271
2016 Q3	–	Sell	-26,022	Closed	-$2.64M	–	4657
2016 Q2	$2.64M	Buy	+26,022	New	+$3.23M	0.01%	1027
2016 Q1	–	Sell	-7,356	Closed	-$2.41M	–	4753
2015 Q4	$2.41M	Buy	7,356 +4,689	+176%	+$1.53M	0.02%	917
2015 Q3	$860K	Sell	2,667 -789	-23%	-$347K	0.01%	1763
2015 Q2	$1.38M	Buy	3,456 +278	+9%	+$118K	0.01%	1284
2015 Q1	$1.56M	Buy	+3,178	New	+$1.23M	0.01%	1044

Other funds holding LUMO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street's LUMO Position: Q1 2020 in Review

Jane Street sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 1,753 shares — an estimated $40K sold.

Jane Street first reported a position in LUMO in Q2 2013 and held it in 13 quarters. The position peaked at $1.54M in Q2 2015. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

Jane Street reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Jane Street sold 1,753 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $40K.
Jane Street first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
Jane Street's Lumos Pharma, Inc. Common Stock position peaked at $1.54M in Q2 2015.
46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.